Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity.
Shah SM, Demidova EV, Ringenbach S, Faezov B, Andrake M, Gandhi A, Mur P, Viana-Errasti J, Xiu J, Swensen J, Valle L, Dunbrack RL Jr, Hall MJ, Arora S. Shah SM, et al. Among authors: swensen j. Cancer Res Commun. 2024 Jan 26;4(1):213-225. doi: 10.1158/2767-9764.CRC-23-0312. Epub 2024 Jan 8. Cancer Res Commun. 2024. PMID: 38282550 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 38207205
Molecular characterization of cancers with NTRK gene fusions.
Gatalica Z, Xiu J, Swensen J, Vranic S. Gatalica Z, et al. Among authors: swensen j. Mod Pathol. 2019 Jan;32(1):147-153. doi: 10.1038/s41379-018-0118-3. Epub 2018 Aug 31. Mod Pathol. 2019. PMID: 30171197 Free article.
Acquired Tertiary MET Resistance (MET D1228N and a Novel LSM8-MET Fusion) to Selpercatinib and Capmatinib in a Patient With KIF5B-RET-positive NSCLC With Secondary MET Amplification as Initial Resistance to Selpercatinib.
Zhu VW, Zhang SS, Zhang J, Swensen J, Xiu J, Ou SI. Zhu VW, et al. Among authors: swensen j. J Thorac Oncol. 2021 Jul;16(7):e51-e54. doi: 10.1016/j.jtho.2021.03.006. J Thorac Oncol. 2021. PMID: 34154791 Free article. No abstract available.
Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.
Seeber A, Battaglin F, Zimmer K, Kocher F, Baca Y, Xiu J, Spizzo G, Novotny-Diermayr V, Rieder D, Puccini A, Swensen J, Ellis M, Goldberg RM, Grothey A, Shields AF, Marshall JL, Weinberg BA, Sackstein PE, Lim KH, Tan GS, Nabhan C, Korn WM, Amann A, Trajanoski Z, Berger MD, Lou E, Wolf D, Lenz HJ. Seeber A, et al. Among authors: swensen j. Clin Cancer Res. 2022 May 2;28(9):1863-1870. doi: 10.1158/1078-0432.CCR-21-3018. Clin Cancer Res. 2022. PMID: 35254413 Free PMC article.
93 results